Home > National Drug Code (NDC) > Dacarbazine

Dacarbazine - 61703-327-22 - (DACARBAZINE)

Alphabetical Index


Drug Information of Dacarbazine

Product NDC: 61703-327
Proprietary Name: Dacarbazine
Non Proprietary Name: DACARBAZINE
Active Ingredient(s): 200    mg/1 & nbsp;   DACARBAZINE
Administration Route(s): INTRAVENOUS
Dosage Form(s): INJECTION, POWDER, FOR SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Dacarbazine

Product NDC: 61703-327
Labeler Name: Hospira Worldwide, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA075940
Marketing Category: ANDA
Start Marketing Date: 20110923

Package Information of Dacarbazine

Package NDC: 61703-327-22
Package Description: 1 VIAL in 1 CARTON (61703-327-22) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL

NDC Information of Dacarbazine

NDC Code 61703-327-22
Proprietary Name Dacarbazine
Package Description 1 VIAL in 1 CARTON (61703-327-22) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL
Product NDC 61703-327
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name DACARBAZINE
Dosage Form Name INJECTION, POWDER, FOR SOLUTION
Route Name INTRAVENOUS
Start Marketing Date 20110923
Marketing Category Name ANDA
Labeler Name Hospira Worldwide, Inc.
Substance Name DACARBAZINE
Strength Number 200
Strength Unit mg/1
Pharmaceutical Classes Alkylating Activity [MoA],Alkylating Drug [EPC]

Complete Information of Dacarbazine


General Information